NIT
ICPT

NumerixS Investment Technologies’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

NumerixS Investment Technologies’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$6K – 1345
2020
Q1 		$6K Buy
+100
New +$8.99K ﹤0.01% 930
2019
Q3 		– Sell
-1,100
Closed -$88K – 1295
2019
Q2 		$88K Buy
+1,100
New +$98.5K 0.03% 633
2018
Q1 		– Sell
-2,400
Closed -$140K – 1326
2017
Q4 		$140K Sell
2,400
-14,181
-86% -$894K 0.03% 574
2017
Q3 		$962K Buy
16,581
+16,081
+3,216% +$1.73M 0.21% 100
2017
Q2 		$61K Buy
+500
New +$57.9K 0.01% 932

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

NumerixS Investment Technologies's ICPT Position: Q2 2020 in Review

NumerixS Investment Technologies sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2020, closing a stake of 100 shares — an estimated $6K sold.

NumerixS Investment Technologies first reported a position in ICPT in Q2 2017 and held it in 5 quarters. The position peaked at $962K in Q3 2017. 192 funds tracked by Wall St. Rank hold ICPT as of Q2 2020.

  • NumerixS Investment Technologies reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 100 Intercept Pharmaceuticals, Inc. shares in Q2 2020, an estimated $6K.
  • NumerixS Investment Technologies first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2017 and held it in 5 quarters.
  • NumerixS Investment Technologies's Intercept Pharmaceuticals, Inc. position peaked at $962K in Q3 2017.
  • 192 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2020.

Based on NumerixS Investment Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.